5801 - 5810 of 8587 Results
Title
Year
-
OPENTitle: Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-73854-yBest OA location URL: https://www.nature.com/articles/s41598-020-73854-y.pdfCitation Count: 8
-
OPENTitle: hipFG: high-throughput harmonization and integration pipeline for functional genomics dataJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 39Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/bioinformatics/btad673Best OA location URL: https://academic.oup.com/bioinformatics/advance-article-pdf/doi/10.1093/bioinformatics/btad673/53050063/btad673.pdfCitation Count: 2
-
OPENTitle: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1632End Page: 1642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27404Citation Count: 15
- Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gaps2024OPENTitle: Leveraging sex-genetic interactions to understand brain disorders: recent advances and current gapsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae192Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae192/58040229/fcae192.pdfCitation Count: 0
- Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders2024OPENTitle: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disordersJournal Name: Bioengineering & Translational MedicinePublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/btm2.10665Best OA location URL: https://doi.org/10.1002/btm2.10665Citation Count: 0
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease2014RESTRICTEDTitle: Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s diseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 265Issue #:Start Page: 245End Page: 252Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.01.042Citation Count: 36
- A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons2017OPENTitle: A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 2Start Page: 306End Page: 319Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5924706Citation Count: 50
- Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications2025OPENTitle: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implicationsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol:Issue #:Start Page: jnnpEnd Page: 335364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2024-335364Best OA location URL: https://doi.org/10.1136/jnnp-2024-335364Citation Count: 2
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://journals.biologists.com/dev/article-pdf/143/10/1649/1842172/dev138412.pdfCitation Count: 0